Knowledge of hepatitis C virus (HCV) status differentially influences the relationship between treatment history and current injection risk behaviors, a recent study suggests. The study sought to assess the role of drug treatment programs and knowledge of HCV status, and how they influence current injection-related risk. Data were collected in 2012 by the New Orleans arm of the National HIV Behavioral Surveillance. Respondent driven sampling was used to recruit a sample of people who inject drugs (PWID). Univariate, bivariate, and linear regression analyses were performed. Researchers found:
- The sample consisted of 473 participants.
- History of drug treatment is associated with sterile syringe use among PWID.
- Knowledge of HCV status modifies the relationships between history of drug treatment and sterile syringe use.
Fisher KA, Cahill LM, Broyles S, Rorke M, Robinson WT. Knowledge of hepatitis C status moderates the relationship between history of drug treatment and sterile syringe use. [Published online ahead of print April 27, 2018]. PLoS One. doi:10.1371/journal.pone.0196157.
Must Reads in Hepatitis
Glecaprevir/Pibrentasvir Efficacy & Safety Assessed, J Hepatol; ePub 2018 Nov 23; D’Ambrosio, et al
HCV Infection Among Children & Young Persons, J Hepatol; ePub 2018 Nov 26; Modin, et al
HCV Patients with Limited Access to Antiviral Therapy, Dig Liver Dis; ePub 2018 Nov 29; Lens, et al
Progression in the Elimination of HCV Infection, PLoS One; ePub 2018 Dec 4; Juanbeltz, et al
Increased HCV Screening in Veteran Populations, Jt Comm J Qual Patient Saf; ePub 2018 Sep 25; Wray, et al